Abstract Objective: To understand the running status of national contraceptives adverse reactions surveillance sites, as well as to provide scientific evidence for improving and strengthening the contraceptives adverse reactions surveillance system.Methods:23 state surveillance sites were selected randomly and evaluated by facetoface interview and by reviewed working records.Results:The mean evaluation score of the included 23 state surveillance sites was 70.09 points. The requirements of Intrauterine devices (IUD) inserted or removed medical record had varied among different surveillance sites, such as family planning service stations, maternal and child health care institutions and hospitals. Reporting rates per million population and under reporting rates of IUD adverse events also had large differences in different surveillance sites. Conclusion: Organizational leadership of contraceptives adverse reactions surveillance should be strengthened, related information collecting should be regulated, and monitoring level of professionalism of surveillance personnel should be promoted.
|
|
|
|
|